Response to: Comment on ‘Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes’ by Kerimoğlu et al.: Cetrorelix in COH cycles: time to re-evaluate the daily administered dose?

Vitro Fertilization ◽

Releasing Hormone

Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration

10.1016/j.fertnstert.2011.06.069 ◽

2011 ◽

Vol 96 (4) ◽

pp. 898-904 ◽

Cited By ~ 9

Author(s):

Anthony M. Propst ◽

Micah J. Hill ◽

Gordon Wright Bates ◽

Michelle Palumbo ◽

Anne K. Van Horne ◽

...

Keyword(s):

In Vitro Fertilization ◽

Luteinizing Hormone ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Low Dose ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Hormone Levels

A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection

10.1016/s0015-0282(01)01977-x ◽

2001 ◽

Vol 76 (3) ◽

pp. 532-537 ◽

Cited By ~ 8

Author(s):

Shigeto Takeuchi ◽

Hiroyuki Minoura ◽

Takashi Shibahara ◽

Yukako Tsuiki ◽

Futamura Noritaka ◽

...

Keyword(s):

In Vitro Fertilization ◽

Intracytoplasmic Sperm Injection ◽

Low Dose ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Buserelin Acetate

Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles**Supported in part by the Vicksburg Hospital Medical Foundation, Vicksburg, Mississippi.

10.1016/s0015-0282(16)57795-4 ◽

1995 ◽

Vol 64 (3) ◽

pp. 573-576 ◽

Cited By ~ 5

Author(s):

Cecil A. Long ◽

Victoria M. Sopelak ◽

Stephen R. Lincoln ◽

Bryan D. Cowan

Keyword(s):

In Vitro Fertilization ◽

Luteal Phase ◽

Low Dose ◽

Agonist Therapy ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Hospital Medical

Optimizing assisted reproduction: impact of low-dose gonadotropin-releasing hormone agonist on in vitro fertilization outcome

10.1016/j.fertnstert.2005.06.050 ◽

2005 ◽

Vol 84 (6) ◽

pp. 1783-1785 ◽

Cited By ~ 2

Author(s):

Elizabeth Lenton ◽

Kamel Mohamed

Keyword(s):

In Vitro Fertilization ◽

Assisted Reproduction ◽

Low Dose ◽

Gonadotropin Releasing Hormone Agonist

Vitro Fertilization ◽

Releasing Hormone ◽

Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes

Archives of Gynecology and Obstetrics ◽

10.1007/s00404-013-2806-z ◽

2013 ◽

Vol 288 (3) ◽

pp. 691-695 ◽

Cited By ~ 4

Author(s):

Özlem Seçilmiş Kerimoğlu ◽

Cihangir Mutlu Ercan ◽

Uğur Keskin ◽

Cem Korkmaz ◽

Namık Kemal Duru ◽

...

Keyword(s):

In Vitro Fertilization ◽

Low Dose ◽

Vitro Fertilization ◽

Releasing Hormone

Comparison of standard and low dose long acting gonadotropin releasing hormone agonist (triptorelin) administration prior to ovarian stimulation for in vitro fertilization

International Journal of Gynecology & Obstetrics ◽

10.1016/s0020-7292(00)81780-4 ◽

2000 ◽

Vol 70 ◽

pp. D40-D40

Author(s):

C.J. Haines ◽

S.F. Yim ◽

L.P. Cheung ◽

C.M. Briton-Jones ◽

T.T.Y. Chin

Keyword(s):

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Low Dose ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Long Acting

Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization

Gynecological Endocrinology ◽

10.1080/09513590400019288 ◽

2004 ◽

Vol 19 (5) ◽

pp. 247-252 ◽

Cited By ~ 4

Author(s):

OM Avrech ◽

R Orvieto ◽

H Pinkas ◽

O Sapir-Rufas ◽

D Feldberg ◽

...

Keyword(s):

In Vitro Fertilization ◽

Low Dose ◽

Controlled Ovarian Hyperstimulation ◽

Ovarian Hyperstimulation ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Hormone Analog

Effect of luteal phase support gonadotropin-releasing hormone agonist on the endometrial receptivity and outcomes of in vitro fertilization programs

GYNECOLOGY ◽

10.26442/2079-5696_18.3.48-53 ◽

2016 ◽

Vol 18 (3) ◽

Cited By ~ 1

Author(s):

E.М. Savelyeva ◽

S.G. Perminova ◽

T.A. Demura ◽

D.A. Strelchenko

Keyword(s):

In Vitro Fertilization ◽

Luteal Phase ◽

Endometrial Receptivity ◽

Gonadotropin Releasing Hormone Agonist

Vitro Fertilization ◽

Releasing Hormone ◽

Luteal Phase Support ◽

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial

10.1016/j.fertnstert.2013.09.035 ◽

2014 ◽

Vol 101 (1) ◽

pp. 147-153 ◽

Cited By ~ 51

Author(s):

Sesh Kamal Sunkara ◽

Arri Coomarasamy ◽

Raef Faris ◽

Peter Braude ◽

Yacoub Khalaf

Keyword(s):

Randomized Controlled Trial ◽

In Vitro Fertilization ◽

Controlled Trial ◽

Poor Responders ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Randomized Controlled

Retrospective analysis of the use of two recombinant follitropin alfa injections in patients undergoing in vitro fertilization treatment with the gonadotropin‐releasing hormone antagonist protocol

Journal of Obstetrics and Gynaecology Research ◽

10.1111/jog.14626 ◽

2020 ◽

Author(s):

Marina Šprem Goldštajn ◽

Stipe Dumančić ◽

Mislav Mikuš

Keyword(s):

In Vitro Fertilization ◽

Retrospective Analysis ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Follitropin Alfa ◽

Antagonist Protocol